AAAAAA

   
Results: 1-23 |
Results: 23
PHASE-I TRIAL OF ANTI-CD3-STIMULATED CD4(-CELLS INFUSIONAL INTERLEUKIN-2, AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED CANCER() T)
Authors: CURTI BD OCHOA AC POWERS GC KOPP WC ALVORD WG JANIK JE GAUSE BL DUNN B KOPRESKI MS FENTON R ZEA A DANSKYULLMANN C STROBL S HARVEY L NELSON E SZNOL M LONGO DL
Citation: Bd. Curti et al., PHASE-I TRIAL OF ANTI-CD3-STIMULATED CD4(-CELLS INFUSIONAL INTERLEUKIN-2, AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED CANCER() T), Journal of clinical oncology, 16(8), 1998, pp. 2752-2760
HIGH-DOSE ALDESLEUKIN IN RENAL-CELL CARCINOMA - LONG-TERM SURVIVAL UPDATE
Authors: FISHER RI ROSENBERG SA SZNOL M PARKINSON DR FYFE G
Citation: Ri. Fisher et al., HIGH-DOSE ALDESLEUKIN IN RENAL-CELL CARCINOMA - LONG-TERM SURVIVAL UPDATE, The cancer journal from Scientific American, 3, 1997, pp. 70-72
CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
Authors: SOSMAN JA ARONSON FR SZNOL M ATKINS MB DUTCHER JP WEISS GR ISAACS RE MARGOLIN KA FISHER RI ERNEST ML MIER J OLEKSOWICZ L ECKHARDT JR LEVITT D DOROSHOW JH
Citation: Ja. Sosman et al., CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY, Clinical cancer research, 3(1), 1997, pp. 39-46
ANTIGEN-SPECIFIC AGENTS IN DEVELOPMENT
Authors: SZNOL M HOLMLUND J
Citation: M. Sznol et J. Holmlund, ANTIGEN-SPECIFIC AGENTS IN DEVELOPMENT, Seminars in oncology, 24(2), 1997, pp. 173-186
PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA
Authors: JANIK JE MILLER LL LONGO DL POWERS GC URBA WJ KOPP WC GAUSE BL CURTI BD FENTON RG OPPENHEIM JJ CONLON KC HOLMLUND JT SZNOL M SHARFMAN WH STEIS RG CREEKMORE SP ALVORD WG BEAUCHAMP AE SMITH JW
Citation: Je. Janik et al., PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA, Journal of the National Cancer Institute, 88(1), 1996, pp. 44-49
A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: FENTON RG STEIS RG MADARA K ZEA AH OCHOA AC JANIK JE SMITH JW GAUSE BL SHARFMAN WH URBA WJ HANNA MG DEJAGER RL COYNE MX CROUCH RD GRAY P BEVERIDGE J CREEKMORE SP HOLMLUND J CURTI BD SZNOL M LONGO DL
Citation: Rg. Fenton et al., A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 364-374
PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER
Authors: GAUSE BL SZNOL M KOPP WC JANIK JE SMITH JW STEIS RG URBA WJ SHARFMAN W FENTON RG CREEKMORE SP HOLMLUND J CONLON KC VANDERMOLEN LA LONGO DL
Citation: Bl. Gause et al., PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2234-2241
LONG-TERM RESPONSE DATA FOR 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY
Authors: FYFE GA FISHER RI ROSENBERG SA SZNOL M PARKINSON DR LOUIE AC
Citation: Ga. Fyfe et al., LONG-TERM RESPONSE DATA FOR 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY, Journal of clinical oncology, 14(8), 1996, pp. 2410-2411
A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2
Authors: HOLMLUND JT KOPP WC WILTROUT RH LONGO DL URBA WJ JANIK JE SZNOL M CONLON KC FENTON RG HORNUNG R MADARA K SHIELDS MA SMITH JW SHARFMAN W STEIS RG EWEL C MALSPEIS L CREEKMORE SP
Citation: Jt. Holmlund et al., A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2, Journal of the National Cancer Institute, 87(2), 1995, pp. 134-136
A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA
Authors: WEISS GR MARGOLIN KA SZNOL M ATKINS MB OLEKSOWICZ L ISAACS R SOSMAN JA DOROSHOW JH TREHU EG DUTCHER JP FISHER RI
Citation: Gr. Weiss et al., A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 52-56
A PHASE-I TRIAL OF B7-TRANSFECTED OR PARENTAL LETHALLY IRRADIATED ALLOGENEIC MELANOMA CELL-LINES TO INDUCE CELL-MEDIATED-IMMUNITY AGAINST TUMOR-ASSOCIATED ANTIGEN PRESENTED BY HLA-A2 OR HLA-A1 IN PATIENTS WITHSTAGE-IV MELANOMA
Authors: FENTON RT SZNOL M LUSTER DG TAUB DD LONGO DL
Citation: Rt. Fenton et al., A PHASE-I TRIAL OF B7-TRANSFECTED OR PARENTAL LETHALLY IRRADIATED ALLOGENEIC MELANOMA CELL-LINES TO INDUCE CELL-MEDIATED-IMMUNITY AGAINST TUMOR-ASSOCIATED ANTIGEN PRESENTED BY HLA-A2 OR HLA-A1 IN PATIENTS WITHSTAGE-IV MELANOMA, Human gene therapy, 6(1), 1995, pp. 87-106
RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY
Authors: FYFE G FISHER RI ROSENBERG SA SZNOL M PARKINSON DR LOUIE AC
Citation: G. Fyfe et al., RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY, Journal of clinical oncology, 13(3), 1995, pp. 688-696
HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
Authors: PARKINSON DR SZNOL M
Citation: Dr. Parkinson et M. Sznol, HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA, Seminars in oncology, 22(1), 1995, pp. 61-66
A PHASE-II TRIAL OF EXTRACORPOREAL PLASMA IMMUNOADSORPTION OF PATIENTPLASMA WITH PROSORBA COLUMNS FOR TREATING METASTATIC BREAST-CANCER
Authors: FENNELLY DW NORTON L SZNOL M HAKES TB
Citation: Dw. Fennelly et al., A PHASE-II TRIAL OF EXTRACORPOREAL PLASMA IMMUNOADSORPTION OF PATIENTPLASMA WITH PROSORBA COLUMNS FOR TREATING METASTATIC BREAST-CANCER, Cancer, 75(8), 1995, pp. 2099-2102
PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
Authors: SPARANO JA FISHER RI WEISS GR MARGOLIN K ARONSON FR HAWKINS MJ ATKINS MB DUTCHER JP GAYNOR ER BOLDT DH DOROSHOW JH ERNEST ML SZNOL M MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
Authors: MARGOLIN K ARONSON FR SZNOL M ATKINS MB GUCALP R FISHER RI SUNDERLAND M DOROSHOW JH ERNEST ML MIER JW DUTCHER JP GAYNOR ER WEISS GR
Citation: K. Margolin et al., PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA
Authors: HAWKINS MJ ATKINS MB DUTCHER JP FISHER RI WEISS GR MARGOLIN KA RAYNER AA SZNOL M PARKINSON DR PAIETTA E GAYNOR ER BOLDT DH DOROSHOW JH ARONSON FR
Citation: Mj. Hawkins et al., A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 74-78
INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES
Authors: SZNOL M PARKINSON DR
Citation: M. Sznol et Dr. Parkinson, INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES, Blood, 83(8), 1994, pp. 2020-2022
PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS
Authors: SOSMAN JA WEISS GR MARGOLIN KA ARONSON FR SZNOL M ATKINS MB OBOYLE K FISHER RI BOLDT DH DOROSHOW J ERNEST ML FISHER SG MIER J VACHINO G CALIENDO G
Citation: Ja. Sosman et al., PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS, Journal of clinical oncology, 11(8), 1993, pp. 1496-1505
RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA
Authors: SPARANO JA FISHER RI SUNDERLAND M MARGOLIN K ERNEST ML SZNOL M ATKINS MB DUTCHER JP MICETICH KC WEISS GR DOROSHOW JH ARONSON FR RUBINSTEIN LV MIER JW
Citation: Ja. Sparano et al., RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA, Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
BIOLOGIC THERAPIES FOR LOW-GRADE LYMPHOMAS
Authors: PARKINSON DR SZNOL M CHESON BD
Citation: Dr. Parkinson et al., BIOLOGIC THERAPIES FOR LOW-GRADE LYMPHOMAS, Seminars in oncology, 20(5), 1993, pp. 111-117
ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS
Authors: JANIK JE SZNOL M URBA WJ FIGLIN R BUKOWSKI RM FYFE G PIERCE WC BELLDEGRUN A SHARFMAN WH SMITH JW LONGO DL
Citation: Je. Janik et al., ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS, Cancer, 72(9), 1993, pp. 2656-2659
BIOLOGICAL RESPONSE MODIFIERS (BRM)IN REFRACTORY MULTIPLE-MYELOMA (MM) - LACK OF CLINICAL EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-4 (RHIL-4) AND ALL-TRANS-RETINOIC ACID (ATRA)
Authors: VESOLE D KORNBLUTH J JAGANNATH S SZNOL M MATTOX S VAUGHT L TRICOT G BARLOGIE B
Citation: D. Vesole et al., BIOLOGICAL RESPONSE MODIFIERS (BRM)IN REFRACTORY MULTIPLE-MYELOMA (MM) - LACK OF CLINICAL EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-4 (RHIL-4) AND ALL-TRANS-RETINOIC ACID (ATRA), Blood, 82(10), 1993, pp. 10000263-10000263
Risultati: 1-23 |